Did you listen to the webcast from Myriad today?Stable disease in 50% of the patients.I think we will here more from these trials during this quarter. Next boarder meeting will set a date for the split of the CO.
There is two phase II trials. The metastasis in the brain shows "more than 50% stable disease or partial response". All to be heard on the Myriad webcast from yesterday.For those of you who are interesting in Epicept as a CO.